Show simple item record

dc.contributor.authorTrapero-Bertran, Marta
dc.contributor.authorLeidl, Reiner
dc.contributor.authorMuñoz, Celia
dc.contributor.authorKulchaitanaroaj, Puttarin
dc.contributor.authorCoyle, Kathryn
dc.contributor.authorPräger, Maximilian
dc.contributor.authorJózwiak‐Hagymásy, Judit
dc.contributor.authorCheung, Kei Long
dc.contributor.authorHiligsmann, Mickaël
dc.contributor.authorPokhrel, Subhash
dc.contributor.authorEQUIPT Study Group
dc.date.accessioned2020-05-24T17:28:08Z
dc.date.available2020-05-24T17:28:08Z
dc.date.issued2018
dc.identifier.citationTrapero‐Bertran, Marta; Leidl, Reiner; Muñoz, Celia [et al.]. Estimates of costs for modelling return on investment from smoking cessation interventions. Addiction, 2018, 113(S1), p. 32-41. Disponible en: <https://onlinelibrary.wiley.com/doi/full/10.1111/add.14091>. Fecha de acceso: 24 may. 2020. DOI: 10.1111/add.14091.ca
dc.identifier.issn1360-0443ca
dc.identifier.urihttp://hdl.handle.net/20.500.12328/1545
dc.description.abstractBackground and aims: Modelling return on investment (ROI) from smoking cessation interventions requires estimates of their costs and benefits. This paper describes a standardized method developed to source both economic costs of tobacco smoking and costs of implementing cessation interventions for a Europe‐wide ROI model [European study on Quantifying Utility of Investment in Protection from Tobacco model (EQUIPTMOD)]. Design: Focused search of administrative and published data. A standardized checklist was developed in order to ensure consistency in methods of data collection. Setting and participants: Adult population (15+ years) in Hungary, Netherlands, Germany, Spain and England. For passive smoking‐related costs, child population (0–15 years) was also included. Measurements: Costs of treating smoking‐attributable diseases; productivity losses due to smoking‐attributable absenteeism; and costs of implementing smoking cessation interventions. Findings: Annual costs (per case) of treating smoking attributable lung cancer were between €5074 (Hungary) and €52 106 (Germany); coronary heart disease between €1521 (Spain) and €3955 (Netherlands); chronic obstructive pulmonary disease between €1280 (England) and €4199 (Spain); stroke between €1829 (Hungary) and €14 880 (Netherlands). Costs (per recipient) of smoking cessation medications were estimated to be: for standard duration of varenicline between €225 (England) and €465 (Hungary); for bupropion between €25 (Hungary) and €220 (Germany). Costs (per recipient) of providing behavioural support were also wide‐ranging: one‐to‐one behavioural support between €34 (Hungary) and €474 (Netherlands); and group‐based behavioural support between €12 (Hungary) and €257 (Germany). The costs (per recipient) of delivering brief physician advice were: €24 (England); €9 (Germany); €4 (Hungary); €33 (Netherlands); and €27 (Spain). Conclusions: Costs of treating smoking‐attributable diseases as well as the costs of implementing smoking cessation interventions vary substantially across Hungary, Netherlands, Germany, Spain and England. Estimates for the costs of these diseases and interventions can contribute to return on investment estimates in support of national or regional policy decisions.ca
dc.format.extent10ca
dc.language.isoengca
dc.publisherWileyca
dc.relation.ispartofAddictionca
dc.relation.ispartofseries113;S1
dc.rights© 2018 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. This is an open access article under the terms ofthe Creative Commons Attribution-NonCommercialLicense, which permits use, distribution and reproductionin any medium, provided the original work is properly cited and is not used for commercial purposesca
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subject.otherHàbit de fumarca
dc.subject.otherTabacca
dc.subject.otherTabaquisme -- Tractamentca
dc.subject.otherCostca
dc.subject.otherGestió de la rendabilitatca
dc.subject.otherInversionsca
dc.subject.otherTabaco -- Consumoca
dc.subject.otherTabacoca
dc.subject.otherTabaquismo -- Tratamientoca
dc.subject.otherCostesca
dc.subject.otherGestión de rentabilidadca
dc.subject.otherInversionesca
dc.subject.otherSmoking -- Habitca
dc.subject.otherTobaccoca
dc.subject.otherSmoking -- Treatmentca
dc.subject.otherCostsca
dc.subject.otherProfit -- Managementca
dc.subject.otherInvestmentsca
dc.titleEstimates of costs for modelling return on investment from smoking cessation interventionsca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/acceptedVersionca
dc.embargo.termscapca
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/602270ca
dc.subject.udc33ca
dc.identifier.doihttps://dx.doi.org/10.1111/add.14091ca


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

© 2018 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. This is an open access article under the terms ofthe Creative Commons Attribution-NonCommercialLicense, which permits use, distribution and reproductionin any medium, provided the original work is properly cited and is not used for commercial purposes
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc/4.0/
Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint